Advertisement
Screener

BIOMERICA INC (BMRA) Operating Lease Liability

2.8 / 5 stars · 68/120 Roast Me

BIOMERICA INC Operating Lease Liability

BIOMERICA INC (BMRA) had Operating Lease Liability of $1.88 million as of 2026-05-31, per its 10-K filed 2026-08-31.

Financial Statements › Balance Sheet › Liabilities

us-gaap:OperatingLeaseLiability · last filed 2026-08-31

  • 2026-05-31: Operating Lease, Liability $1.88M.
  • 2026-02-28: Operating Lease, Liability $193.00K.
  • 2025-11-30: Operating Lease, Liability $284.00K.
  • 2025-08-31: Operating Lease, Liability $373.00K.
Period endOperating Lease, Liability
2026-05-31$1.88M
10-K · filed 2026-08-31
2026-02-28$193.00K
10-Q · filed 2026-04-13
2025-11-30$284.00K
10-Q · filed 2026-01-14
2025-08-31$373.00K
10-Q · filed 2025-10-14
2025-05-31$458.00K
10-K · filed 2025-08-29
2025-02-28$543.00K
10-Q · filed 2025-04-14
2024-11-30$626.00K
10-Q · filed 2025-01-14
2024-08-31$707.00K
10-Q · filed 2024-10-15
2024-05-31$785.00K
10-K · filed 2024-08-28
2024-02-29$862.00K
10-Q · filed 2024-04-12
2023-11-30$937.00K
10-Q · filed 2024-01-16
2023-08-31$1.01M
10-Q · filed 2023-10-12
2023-05-31$1.08M
10-K · filed 2023-08-25
2023-02-28$1.18M
10-Q · filed 2023-04-14
2022-11-30$1.25M
10-Q · filed 2023-01-13
2022-08-31$1.31M
10-Q · filed 2022-10-13
2022-05-31$1.38M
10-K · filed 2022-08-29
2022-02-28$1.44M
10-Q · filed 2022-04-14
2021-11-30$1.50M
10-Q · filed 2022-01-12
2021-08-31$1.56M
10-Q · filed 2021-10-14
2021-05-31$1.62M
10-K/A · filed 2021-10-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92